Potassium in PDB 2qki: Human C3C in Complex with the Inhibitor Compstatin
Protein crystallography data
The structure of Human C3C in Complex with the Inhibitor Compstatin, PDB code: 2qki
was solved by
B.J.C.Janssen,
E.F.Halff,
J.D.Lambris,
P.Gros,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
33.00 /
2.40
|
Space group
|
P 1 21 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
85.809,
124.754,
127.367,
90.00,
95.08,
90.00
|
R / Rfree (%)
|
21.3 /
28.1
|
Other elements in 2qki:
The structure of Human C3C in Complex with the Inhibitor Compstatin also contains other interesting chemical elements:
Potassium Binding Sites:
The binding sites of Potassium atom in the Human C3C in Complex with the Inhibitor Compstatin
(pdb code 2qki). This binding sites where shown within
5.0 Angstroms radius around Potassium atom.
In total 5 binding sites of Potassium where determined in the
Human C3C in Complex with the Inhibitor Compstatin, PDB code: 2qki:
Jump to Potassium binding site number:
1;
2;
3;
4;
5;
Potassium binding site 1 out
of 5 in 2qki
Go back to
Potassium Binding Sites List in 2qki
Potassium binding site 1 out
of 5 in the Human C3C in Complex with the Inhibitor Compstatin
Mono view
Stereo pair view
|
A full contact list of Potassium with other atoms in the K binding
site number 1 of Human C3C in Complex with the Inhibitor Compstatin within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:K3002
b:57.8
occ:1.00
|
O
|
A:VAL533
|
2.6
|
42.0
|
1.0
|
O
|
A:PRO505
|
2.8
|
35.2
|
1.0
|
OD1
|
A:ASP535
|
2.9
|
47.5
|
1.0
|
OD1
|
A:ASP532
|
3.0
|
46.0
|
1.0
|
OD2
|
A:ASP532
|
3.3
|
44.6
|
1.0
|
CG
|
A:ASP532
|
3.4
|
43.3
|
1.0
|
CG
|
A:ASP535
|
3.6
|
46.8
|
1.0
|
C
|
A:PRO505
|
3.8
|
35.2
|
1.0
|
C
|
A:VAL533
|
3.8
|
42.0
|
1.0
|
O
|
A:HOH3106
|
3.8
|
51.4
|
1.0
|
OD2
|
A:ASP535
|
4.1
|
47.8
|
1.0
|
CA
|
A:PRO505
|
4.1
|
35.4
|
1.0
|
N
|
A:VAL533
|
4.1
|
40.7
|
1.0
|
N
|
A:ASP535
|
4.2
|
45.0
|
1.0
|
CA
|
A:VAL533
|
4.6
|
41.1
|
1.0
|
C
|
A:LYS534
|
4.6
|
44.5
|
1.0
|
CB
|
A:ASP535
|
4.7
|
46.1
|
1.0
|
N
|
A:LYS534
|
4.7
|
42.6
|
1.0
|
CA
|
A:LYS534
|
4.7
|
43.9
|
1.0
|
CA
|
A:ASP535
|
4.8
|
45.8
|
1.0
|
CB
|
A:ASP532
|
4.8
|
40.9
|
1.0
|
CB
|
A:PRO505
|
4.9
|
35.1
|
1.0
|
N
|
A:SER506
|
5.0
|
35.0
|
1.0
|
|
Potassium binding site 2 out
of 5 in 2qki
Go back to
Potassium Binding Sites List in 2qki
Potassium binding site 2 out
of 5 in the Human C3C in Complex with the Inhibitor Compstatin
Mono view
Stereo pair view
|
A full contact list of Potassium with other atoms in the K binding
site number 2 of Human C3C in Complex with the Inhibitor Compstatin within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
C:K602
b:64.3
occ:1.00
|
O
|
C:HOH522
|
2.7
|
76.3
|
1.0
|
O
|
C:ARG1405
|
2.8
|
47.5
|
1.0
|
O
|
C:GLY1402
|
2.9
|
49.4
|
1.0
|
O
|
C:ALA1400
|
2.9
|
47.4
|
1.0
|
C
|
C:GLY1402
|
3.8
|
49.4
|
1.0
|
C
|
C:ARG1405
|
4.0
|
47.7
|
1.0
|
C
|
C:ALA1400
|
4.1
|
47.3
|
1.0
|
N
|
C:ARG1405
|
4.3
|
48.8
|
1.0
|
C
|
C:ASN1401
|
4.3
|
48.3
|
1.0
|
N
|
C:GLY1402
|
4.4
|
48.7
|
1.0
|
CA
|
C:ASN1401
|
4.4
|
48.1
|
1.0
|
CA
|
C:VAL1403
|
4.4
|
49.9
|
1.0
|
N
|
C:VAL1403
|
4.5
|
49.7
|
1.0
|
N
|
C:ASP1404
|
4.5
|
49.7
|
1.0
|
O
|
C:ASN1401
|
4.7
|
48.3
|
1.0
|
CA
|
C:ARG1405
|
4.7
|
48.3
|
1.0
|
N
|
C:ASN1401
|
4.8
|
47.8
|
1.0
|
C
|
C:VAL1403
|
4.8
|
49.9
|
1.0
|
CA
|
C:GLY1402
|
4.8
|
49.1
|
1.0
|
|
Potassium binding site 3 out
of 5 in 2qki
Go back to
Potassium Binding Sites List in 2qki
Potassium binding site 3 out
of 5 in the Human C3C in Complex with the Inhibitor Compstatin
Mono view
Stereo pair view
|
A full contact list of Potassium with other atoms in the K binding
site number 3 of Human C3C in Complex with the Inhibitor Compstatin within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
D:K3002
b:41.6
occ:1.00
|
O
|
D:VAL533
|
2.6
|
48.9
|
1.0
|
O
|
D:PRO505
|
2.6
|
41.6
|
1.0
|
OD1
|
D:ASP535
|
2.7
|
54.0
|
1.0
|
OD1
|
D:ASP532
|
2.7
|
47.8
|
1.0
|
O
|
D:HOH3171
|
3.1
|
37.4
|
1.0
|
C
|
D:VAL533
|
3.7
|
48.4
|
1.0
|
C
|
D:PRO505
|
3.7
|
41.7
|
1.0
|
CG
|
D:ASP535
|
3.8
|
52.4
|
1.0
|
CG
|
D:ASP532
|
3.8
|
48.1
|
1.0
|
N
|
D:ASP535
|
3.9
|
50.9
|
1.0
|
N
|
D:VAL533
|
4.1
|
47.1
|
1.0
|
CA
|
D:PRO505
|
4.3
|
41.8
|
1.0
|
OD2
|
D:ASP532
|
4.3
|
50.4
|
1.0
|
C
|
D:LYS534
|
4.3
|
50.7
|
1.0
|
CA
|
D:ASP535
|
4.4
|
50.7
|
1.0
|
CB
|
D:ASP535
|
4.5
|
51.1
|
1.0
|
CA
|
D:VAL533
|
4.5
|
47.6
|
1.0
|
OE2
|
D:GLU599
|
4.5
|
54.7
|
1.0
|
N
|
D:LYS534
|
4.6
|
49.6
|
1.0
|
CA
|
D:LYS534
|
4.6
|
50.4
|
1.0
|
OD2
|
D:ASP535
|
4.7
|
54.8
|
1.0
|
CB
|
D:PRO505
|
4.8
|
41.4
|
1.0
|
N
|
D:SER506
|
4.8
|
42.0
|
1.0
|
O
|
D:LYS534
|
4.9
|
51.1
|
1.0
|
C
|
D:ASP532
|
5.0
|
46.4
|
1.0
|
|
Potassium binding site 4 out
of 5 in 2qki
Go back to
Potassium Binding Sites List in 2qki
Potassium binding site 4 out
of 5 in the Human C3C in Complex with the Inhibitor Compstatin
Mono view
Stereo pair view
|
A full contact list of Potassium with other atoms in the K binding
site number 4 of Human C3C in Complex with the Inhibitor Compstatin within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
D:K3003
b:80.5
occ:1.00
|
NH2
|
D:ARG13
|
2.8
|
44.2
|
1.0
|
O
|
D:ALA601
|
2.8
|
43.1
|
1.0
|
C
|
D:ALA601
|
3.4
|
43.6
|
1.0
|
O
|
D:LYS475
|
3.5
|
41.0
|
1.0
|
C
|
D:LYS475
|
3.7
|
41.4
|
1.0
|
CZ
|
D:ARG13
|
3.7
|
46.1
|
1.0
|
NH1
|
D:ARG13
|
3.8
|
47.4
|
1.0
|
CB
|
D:ALA601
|
3.9
|
42.8
|
1.0
|
N
|
D:ASP602
|
4.0
|
44.3
|
1.0
|
CA
|
D:ASP602
|
4.1
|
45.2
|
1.0
|
N
|
D:GLY476
|
4.1
|
41.7
|
1.0
|
OH
|
D:TYR107
|
4.1
|
44.9
|
1.0
|
CA
|
D:GLY476
|
4.2
|
42.2
|
1.0
|
CA
|
D:ALA601
|
4.3
|
43.4
|
1.0
|
CA
|
D:LYS475
|
4.3
|
41.1
|
1.0
|
O
|
D:VAL598
|
4.4
|
42.3
|
1.0
|
N
|
D:ILE603
|
4.6
|
44.8
|
1.0
|
C
|
D:ASP602
|
4.7
|
45.1
|
1.0
|
CG2
|
D:ILE603
|
4.8
|
43.4
|
1.0
|
BR
|
D:BR703
|
4.8
|
54.0
|
0.8
|
CB
|
D:HIS132
|
4.9
|
44.0
|
1.0
|
NE
|
D:ARG13
|
5.0
|
46.3
|
1.0
|
|
Potassium binding site 5 out
of 5 in 2qki
Go back to
Potassium Binding Sites List in 2qki
Potassium binding site 5 out
of 5 in the Human C3C in Complex with the Inhibitor Compstatin
Mono view
Stereo pair view
|
A full contact list of Potassium with other atoms in the K binding
site number 5 of Human C3C in Complex with the Inhibitor Compstatin within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
F:K605
b:51.1
occ:1.00
|
O
|
F:ARG1405
|
2.7
|
39.6
|
1.0
|
O
|
F:GLY1402
|
2.8
|
43.6
|
1.0
|
O
|
F:ALA1400
|
2.9
|
44.7
|
1.0
|
C
|
F:ARG1405
|
3.8
|
40.1
|
1.0
|
C
|
F:GLY1402
|
3.9
|
43.5
|
1.0
|
O
|
F:ASN1401
|
4.0
|
43.6
|
1.0
|
C
|
F:ALA1400
|
4.1
|
44.3
|
1.0
|
C
|
F:ASN1401
|
4.1
|
43.8
|
1.0
|
O
|
F:VAL1403
|
4.3
|
43.2
|
1.0
|
N
|
F:ARG1405
|
4.4
|
41.4
|
1.0
|
CA
|
F:ASN1401
|
4.5
|
44.1
|
1.0
|
N
|
F:GLY1402
|
4.5
|
43.6
|
1.0
|
C
|
F:VAL1403
|
4.6
|
43.0
|
1.0
|
CA
|
F:ARG1405
|
4.6
|
40.8
|
1.0
|
CA
|
F:VAL1403
|
4.7
|
43.1
|
1.0
|
N
|
F:ASN1401
|
4.7
|
44.2
|
1.0
|
N
|
F:VAL1403
|
4.8
|
43.4
|
1.0
|
N
|
F:TYR1406
|
4.8
|
39.8
|
1.0
|
CA
|
F:GLY1402
|
4.8
|
43.7
|
1.0
|
CA
|
F:TYR1406
|
4.9
|
38.9
|
1.0
|
|
Reference:
B.J.Janssen,
E.F.Halff,
J.D.Lambris,
P.Gros.
Structure of Compstatin in Complex with Complement Component C3C Reveals A New Mechanism of Complement Inhibition. J.Biol.Chem. V. 282 29241 2007.
ISSN: ISSN 0021-9258
PubMed: 17684013
DOI: 10.1074/JBC.M704587200
Page generated: Mon Aug 12 06:54:45 2024
|